TipRanks
Pharming Group (PHAR)
NASDAQ:PHAR
US Market
PHAR
Pharming Group
RESEARCH TOOLSreports
Want to see PHAR full AI Analyst Report?

Pharming Group (PHAR) Stock News & Sentiment

240 Followers
Pharming Group: Buy Rating Maintained and Strategy Intact Despite Surprise CEO Departure; Price Target Reaffirmed at $38
Premium
Ratings
Pharming Group: Buy Rating Maintained and Strategy Intact Despite Surprise CEO Departure; Price Target Reaffirmed at $38
3d ago
PHAR
Buy Rating Reaffirmed on Joenja’s European Expansion and Pediatric FDA Catalyst; $37 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on Joenja’s European Expansion and Pediatric FDA Catalyst; $37 Price Target Maintained
3M ago
PHAR
Pharming: Profitable Core, Advancing Pipeline Underpin Buy Rating and Maintained $37 Price Target
Premium
Ratings
Pharming: Profitable Core, Advancing Pipeline Underpin Buy Rating and Maintained $37 Price Target
3M ago
PHAR
Pharming Wins FDA Review for Joenja Pediatric sNDA in APDS
Premium
Company Announcements
Pharming Wins FDA Review for Joenja Pediatric sNDA in APDS
4M ago
6K
PHAR
Pharming Group appoints KPMG as new auditor as shareholders back full AGM agenda
Premium
Company Announcements
Pharming Group appoints KPMG as new auditor as shareholders back full AGM agenda
4M ago
6K
PHAR
Pantginis Reiterates Buy on Pharming as Joenja’s Global Expansion Advances; $37 Price Target Maintained
Premium
Ratings
Pantginis Reiterates Buy on Pharming as Joenja’s Global Expansion Advances; $37 Price Target Maintained
4M ago
PHAR
Pharming Wins EU Green Light for Joenja, First Approved Treatment for APDS
Premium
Company Announcements
Pharming Wins EU Green Light for Joenja, First Approved Treatment for APDS
4M ago
6K
PHAR
More PHAR News >

PHAR News on the Web

Pharming announces ‘positive’ Phase 2 topline data for leniolisib in PIDs
TipRanks News
Neutral
Pharming Group (PHAR) Expands Joenja’s Pediatric Label. Can Growth Offset RUCONEST Weakness?
Insider Monkey
Neutral
Buy Rating Reaffirmed on Joenja’s European Expansion and Pediatric FDA Catalyst; $37 Price Target Maintained
TipRanks News
Bullish
Pharming: Profitable Core, Advancing Pipeline Underpin Buy Rating and Maintained $37 Price Target
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Pharming Group appoints KPMG as new auditor as shareholders back full AGM agenda
TipRanks News
Neutral
Pantginis Reiterates Buy on Pharming as Joenja’s Global Expansion Advances; $37 Price Target Maintained
TipRanks News
Bullish
Pharming Group Receives EU Approval For Joenja In Rare Immunodeficiency
rttnews
Bullish

News Score - Last 7 Days

Very Positive
PHAR
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PHAR’s Media Buzz Sentiment?
4 articles about PHAR were published this week. In an average week, 1.75 articles are published.
    What is PHAR’s weekly average amount of articles?
    In an average week, 1.75 articles about PHAR are published.
      What is PHAR’s News Sentiment?
      100% of articles about PHAR were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SYRESpyre Therapeutics
        BAYRYBayer
        QTTBQ32 Bio
        CICigna
        ZYMEZymeworks
        Showing the stocks with the most bullish news sentiment over the past week